摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(3,4-Dihydroxyphenyl)-4h-chromene-3,5,7-triol

中文名称
——
中文别名
——
英文名称
2-(3,4-Dihydroxyphenyl)-4h-chromene-3,5,7-triol
英文别名
——
2-(3,4-Dihydroxyphenyl)-4h-chromene-3,5,7-triol化学式
CAS
——
化学式
C15H12O6
mdl
——
分子量
288.25
InChiKey
MBKCCFSHAHNZMT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    21
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    110
  • 氢给体数:
    5
  • 氢受体数:
    6

文献信息

  • Positive type photoresist composition
    申请人:FUJI PHOTO FILM CO., LTD.
    公开号:EP0445680A2
    公开(公告)日:1991-09-11
    A positive type photoresist composition which is superior in the prevention of pattern break and scumming during development, comprising an alkali-soluble novolak resin and a 1,2-quinonediazide compound, wherein said novolak resin is a condensate of a mixture of m-cresol and p-cresol with at least one of formaldehyde, formaldehyde polymer and formaldehyde precursor and wherein the relationship between X = A/(A+B+C) and the content of m-cresol in said novolak resin falls within the shaded part (including the straight lines surrounding this part) in Figure 1, said A representing an integrated value of peak area between 23.0 ppm and 31.0 ppm , B representing an integrated value of peak area between 31.0 ppm and 34.0 ppm and C representing an integrated value of peak area between 34.0 ppm and 37.0 ppm in a ¹³C-NMR spectrum of a dimethyl sulfoxide-d₆ solution of said novolak resin.
    一种正型光刻胶组合物,在显影过程中可有效防止图案破裂和浮渣,该组合物由碱溶性树脂和 1,2-醌噻嗪化合物组成,其中所述树脂间甲酚对甲酚甲醛甲醛聚合物和甲醛前体中至少一种的混合物的缩合物、其中,X = A/(A+B+C) 与间甲酚在所述树脂中的含量之间的关系在图 1 中的阴影部分(包括围绕该部分的直线)内,所述 A 代表峰面积的综合值,介于 23.在所述树脂二甲亚砜-d₆溶液的¹³C-NMR 光谱中,A 代表峰面积的综合值在 23.0 ppm 和 31.0 ppm 之间,B 代表峰面积的综合值在 31.0 ppm 和 34.0 ppm 之间,C 代表峰面积的综合值在 34.0 ppm 和 37.0 ppm 之间。
  • Chemosensory receptor ligand-based therapies
    申请人:Anji Pharma (US) LLC
    公开号:US10610500B2
    公开(公告)日:2020-04-07
    Provided herein are methods for treating conditions associated with a chemosensory receptor, including diabetes, obesity, and other metabolic diseases, disorders or conditions by administrating a composition comprising a chemosensory receptor ligand, such as a bitter receptor ligand. Also provided herein are chemosensory receptor ligand compositions, including bitter receptor ligand compositions, and methods for the preparation thereof for use in the methods of the present invention. Also provided herein are compositions comprising metformin and salts thereof and methods of use.
    本文提供了通过施用包含化感受体配体(如苦味受体配体)的组合物来治疗与化感受体相关的病症(包括糖尿病、肥胖症和其他代谢性疾病、失调或病症)的方法。本文还提供了化学感觉受体配体组合物,包括苦味受体配体组合物,及其用于本发明方法的制备方法。本文还提供了包含二甲双胍及其盐类的组合物和使用方法。
  • Hydrolyzed pea protein-based nutrient composition
    申请人:Kate Farms, Inc.
    公开号:US10806169B2
    公开(公告)日:2020-10-20
    The present invention discloses a nutritional composition and method of using and making the nutritional composition. The nutritional composition is a hydrolyzed pea protein based nutrient composition for use in both enteral and oral feeding, and provides a non-allergenic diet for providing optimal nutrition to users. The nutritional composition is made from organic and plant-based ingredients. The nutritional composition has pea protein hydrolysates, phytochemical extracts, fatty acids, organic ingredients free of the top eight allergens and corn, and prebiotic fiber. The nutritional composition is provided in liquid form for enteral and/or oral feeding.
    本发明公开了一种营养组合物以及使用和制造该营养组合物的方法。该营养组合物是一种基于解豌豆蛋白的营养组合物,既可用于肠道喂养,也可用于口服喂养,可提供无过敏饮食,为使用者提供最佳营养。该营养组合物由有机成分和植物成分制成。该营养组合物含有豌豆蛋白解物、植物化学提取物脂肪酸、不含八大过敏原和玉米的有机成分以及益生纤维。营养组合物以液体形式提供,用于肠道和/或口服喂养。
  • Novel crystal modifications, processes for their production, and pharmaceutical preparations containing them
    申请人:Zyma SA
    公开号:EP0087164B1
    公开(公告)日:1987-05-27
  • Positive photoresist composition
    申请人:FUJI PHOTO FILM CO., LTD.
    公开号:EP0555861B1
    公开(公告)日:1998-11-11
查看更多